Bedrijfstakpensioenfonds Voor De Media Pno Lowers stake in Colgate-Palmolive Company (CL)

Colgate-Palmolive Company (CL) : Bedrijfstakpensioenfonds Voor De Media Pno reduced its stake in Colgate-Palmolive Company by 1.92% during the most recent quarter end. The investment management company now holds a total of 255,100 shares of Colgate-Palmolive Company which is valued at $18,091,692 after selling 5,000 shares in Colgate-Palmolive Company , the firm said in a disclosure report filed with the SEC on Apr 25, 2016.Colgate-Palmolive Company makes up approximately 2.60% of Bedrijfstakpensioenfonds Voor De Media Pno’s portfolio.

Colgate-Palmolive Company opened for trading at $71.47 and hit $72.39 on the upside on Monday, eventually ending the session at $72.37, with a gain of 2.04% or 1.45 points. The heightened volatility saw the trading volume jump to 46,87,451 shares. Company has a market cap of $64,628 M.

Other Hedge Funds, Including , Concannon Wealth Management added CL to its portfolio by purchasing 1,200 company shares during the most recent quarter which is valued at $82,872. Colgate-Palmolive Company makes up approx 0.08% of Concannon Wealth Management’s portfolio.Portland Global Advisors reduced its stake in CL by selling 200 shares or 3.27% in the most recent quarter. The Hedge Fund company now holds 5,923 shares of CL which is valued at $409,042. Colgate-Palmolive Company makes up approx 0.19% of Portland Global Advisors’s portfolio.Bremer Trust National Association reduced its stake in CL by selling 984 shares or 2.02% in the most recent quarter. The Hedge Fund company now holds 47,836 shares of CL which is valued at $3,408,315. Colgate-Palmolive Company makes up approx 0.97% of Bremer Trust National Association’s portfolio. Intermede Investment Partners Ltd sold out all of its stake in CL during the most recent quarter. The investment firm sold 254,535 shares of CL which is valued $18,135,619.

On the company’s financial health, Colgate-Palmolive Company reported $0.63 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.63. The company had revenue of $3762.00 million for the quarter, compared to analysts expectations of $3760.63 million. The company’s revenue was down -7.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.66 EPS.

Many Wall Street Analysts have commented on Colgate-Palmolive Company. Colgate-Palmolive Company was Upgraded by Goldman to ” Neutral” on May 2, 2016. Company shares were Reiterated by UBS on Apr 29, 2016 to “Neutral”, Firm has raised the Price Target to $ 76 from a previous price target of $73 .Colgate-Palmolive Company was Downgraded by Sterne Agee CRT to ” Neutral” on Feb 26, 2016.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in more than 200 countries and territories throughout the world. The Company operates in two product segments: Oral Personal and Home Care and Pet Nutrition. The Oral Personal and Home Care product segment is operated through five geographic segments: North America Latin America Europe/South Pacific Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Optic White and Colgate Luminous White toothpastes among others. The Company sells its personal care products under the Palmolive Protex and Softsoap brands. The Company through its Hill’s Pet Nutrition segment (Hill’s) manufactures pet nutrition products for dogs and cats.

Leave a Reply

Colgate-Palmolive Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Colgate-Palmolive Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.